Altered DNA Mismatch Repair Expression in Synchronous and Metachronous Colorectal Cancers

Clinical Gastroenterology and Hepatology

Volumn 6, Issue 12, 2008, Pages 1385-1388

  Aslanian, Harry R ^a   Burgart, Lawrence J ^b   Harrington, Jonathan J ^c   Mahoney, Douglas W ^c   Zinsmeister, Alan R ^c   Thibodeau, Stephen N ^c   Ahlquist, David A ^c  

^a YALE UNIVERSITY   (United States)

^b ABBOTT NORTHWESTERN HOSPITAL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE; GENE EXPRESSION; GENE LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MLH1 GENE; MSH2 GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; NUCLEAR PROTEINS;

EID: 57149092615     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.04.027     Document Type: Article

References (22)

1. Peltomaki P., and Vasen H.F. Mutations predisposing to HNPCC: database and results of a collaborative study. Gastroenterology 113 (1997) 1146-1158
2. Ahlquist D.A. Aggressive polyps in HNPCC: targets for screening. Gastroenterology 108 (1995) 1590-1592
3. Lynch H.T., Watson P., Kriegler M., et al. Differential diagnosis of hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 31 (1988) 372-377
4. Lynch H., Smyrk T., and Lynch J. An update of HNPCC. Cancer Genet Cytoget 93 (1997) 84-99
5. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. National Cancer Institute Workshop on HNPCC. JNCI 96 (2004) 261-268
6. Aaltonen L., Salovaara R., Kristo P., et al. Incidence of HNPCC and the feasibility of molecular screening for the disease. N Engl J Med 338 (1998) 1481-1487
7. Wijnen J., Vasen H., Khan M., et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 339 (1998) 511-518
8. Hampel H., Frankel W., Martin E., et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352 (2005) 1851-1860
9. Thibodeau S.N., French A.J., and Cunningham J.M. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 58 (1998) 1713-1718
10. Vasen H.F., Watson P., Mecklin J.P., et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116 (1999) 1453-1456
11. Velayos F.S., Lee S.H., Qiu H., et al. The mechanism of microsatellite instability is different in synchronous and metachronous colorectal cancer. J Gastrointest Surg 9 (2005) 329-335
12. Cawkwell C., Gray S., Murgatroyd H., et al. Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut 45 (1999) 409-415
13. Pinol V., Castells A., Andreu M., et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 293 (2005) 1986-1994
14. Lawes D., Pearson T., SenGupta S., et al. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers. Br J Cancer 93 (2005) 472-477
15. Fink D., Nebel S., Norris P.S., et al. The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells. Br J Cancer 77 (1998) 703-708
16. Ribic C.M., Sargent D.J., Moore M.J., et al. Tumor microsatellite instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349 (2003) 247-257
17. Carethers J.M., Smith E.J., Behling C.A., et al. Use of 5-fluorouracil and survival in patients with microsatellite unstable colorectal cancer. Gastroenterology 126 (2004) 394-401
18. Lindblom A. Different mechanisms of tumorigenesis of proximal and distal colon cancers. Curr Opin Oncol 13 (2001) 63-69
19. Sawhney M.S., Farrar W.D., Gudiseva S., et al. Microsatellite instability in interval colon cancers. Gastroenterology 131 (2006) 1700-1705
20. Gervaz P., Bucher P., Neyroud-Caspar I., et al. Proximal location of colon cancer is a risk factor for development of metachronous colorectal cancer: a population based study. Dis Colon Rectum 48 (2005) 227-232
21. Balmana J., Stockwell D.H., Steyerberg E.W., et al. Prediction of MLH1 and MAH2 mutations in Lynch syndrome. JAMA 296 (2006) 1469-1478
22. Peltomaki P. Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 7 (2001) 735-740